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ABSTRACT Campylobacter jejuni is a pathogenic bacterium that causes gastroenteri-
tis in humans yet is a widespread commensal in wild and domestic animals, particu-
larly poultry. Using RNA sequencing, we assessed C. jejuni transcriptional responses
to medium supplemented with human fecal versus chicken cecal extracts and in
extract-supplemented medium versus medium alone. C. jejuni exposed to extracts
had altered expression of 40 genes related to iron uptake, metabolism, chemotaxis,
energy production, and osmotic stress response. In human fecal versus chicken cecal
extracts, C. jejuni displayed higher expression of genes involved in respiration
(fdhTU) and in known or putative iron uptake systems (cfbpA, ceuB, chuC, and
CJJ81176_1649–1655 [here designated 1649–1655]). The 1649–1655 genes and
downstream overlapping gene 1656 were investigated further. Uncharacterized ho-
mologues of this system were identiﬁed in 33 diverse bacterial species representing
6 different phyla, 21 of which are associated with human disease. The 1649 and
1650 (p19) genes encode an iron transporter and a periplasmic iron binding protein,
respectively; however, the role of the downstream 1651–1656 genes was unknown.
A 1651–1656 deletion strain had an iron-sensitive phenotype, consistent with a pre-
viously characterized p19 mutant, and showed reduced growth in acidic medium,
increased sensitivity to streptomycin, and higher resistance to H2O2 stress. In iron-
restricted medium, the 1651–1656 and p19 genes were required for optimal growth
when using human fecal extracts as an iron source. Collectively, this implicates a
function for the 1649–1656 gene cluster in C. jejuni iron scavenging and stress sur-
vival in the human intestinal environment.
IMPORTANCE Direct comparative studies of C. jejuni infection of a zoonotic com-
mensal host and a disease-susceptible host are crucial to understanding the causes
of infection outcome in humans. These studies are hampered by the lack of a
disease-susceptible animal model reliably displaying a similar pathology to human
campylobacteriosis. In this work, we compared the phenotypic and transcriptional
responses of C. jejuni to intestinal compositions of humans (disease-susceptible host)
and chickens (zoonotic host) by using human fecal and chicken cecal extracts. The
mammalian gut is a complex and dynamic system containing thousands of metabo-
lites that contribute to host health and modulate pathogen activity. We identiﬁed
C. jejuni genes more highly expressed during exposure to human fecal extracts in
comparison to chicken cecal extracts and differentially expressed in extracts com-
pared with medium alone, and targeted one speciﬁc iron uptake system for further
molecular, genetic, and phenotypic study.
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Campylobacter jejuni is a leading bacterial cause of human foodborne illness world-wide in both developed and developing nations (1, 2). This zoonotic bacterium
asymptomatically colonizes the digestive tracts of wild and domestic animals, with
population colonization rates measured as high as 86% (3–6). The most common
reservoir of C. jejuni transmission to humans is poultry, particularly chickens. C. jejuni
can colonize chicken ceca, which are two blind pouches at the junction of the small and
large intestines, to concentrations as high as 2.5  109 CFU/g cecal material without
signs of pathology (7, 8). In humans, C. jejuni infection can result in sporadic cases or
localized outbreaks of disease due to ingestion of contaminated meat, water, or
unpasteurized milk and improper handling of animals (1, 9, 10). Accidental ingestion of
as little as a few hundred bacterial cells can cause severe but typically self-limiting acute
gastrointestinal illness ranging from mild to bloody diarrhea, nausea, and vomiting as
early as 17 h postingestion and lasting from days to weeks (11–13). During human
infection, C. jejuni colonizes the large intestine and can replicate to concentrations as
high as 3.0  108 CFU/g fecal material (12). C. jejuni infection can also cause long-term
chronic inﬂammatory bowel diseases (e.g., Crohn’s disease, ulcerative colitis, and
colorectal cancer) and autoimmune inﬂammatory demyelination diseases (e.g., Guillain-
Barré and Miller-Fisher syndromes) in a small percentage of infected individuals (14, 15).
Despite extensive study, it remains enigmatic why C. jejuni causes such acute human
disease but harmlessly colonizes its zoonotic hosts, such as chickens.
The intestinal metabolome is a complex and dynamic system consisting of thou-
sands of metabolites that both contribute and respond to intestinal health (16–18). The
known metabolites, including short-chain fatty acids (SCFAs), organic acids, bile salts,
lipids, amino acids, vitamins, and trace minerals (17), only account for a small fraction
of the metabolome, with thousands of as yet unidentiﬁed metabolites that may play a
role in intestinal health (19). Salmonella enterica serovar Typhimurium was recently
shown to respond to human fecal metabolites by increasing the expression of genes
related to metabolism, motility, and chemotaxis, reducing the expression of genes
involved in host cell invasion, and reducing pathogen invasion of HeLa cells (19). The
metabolomes of the chicken ceca and the human large intestine are expected to be
dissimilar due to factors such as differences in diet, digestive system structure and
function, host defense peptides, and the resident microbiome (20–22). These factors
also contribute to the availability of trace metals and micronutrients, such as iron, that
are essential for bacterial cell growth and host colonization (23–25). We thus hypoth-
esized that C. jejuni exposed to human fecal extracts would respond by altering
expression of genes speciﬁcally required for human infection.
In this study, we compared phenotypic and gene expression differences in C. jejuni
cells exposed to medium containing sterile intestinal extracts of the disease-susceptible
host (humans) versus the commensal host (chickens). Among the differentially ex-
pressed genes, we selected one putative and as yet uncharacterized iron uptake gene
cluster (CJJ81176_1649–1656) for further study, as it was signiﬁcantly more highly
expressed during growth in medium with extracts compared to medium alone, and in
particular in medium containing human fecal compared to chicken cecal extracts. This
gene cluster is here referred to as “1649–1656,” and all genes discussed throughout the
article will use the CJJ81176 gene locus numbers and protein designations. Collectively,
this work shows that C. jejuni responds differentially to metabolites present in the
intestinal lumen of commensal versus susceptible hosts, provides a broad database
repository of the C. jejuni transcriptional gene responses to these conditions, and shows
that the 1649–1656 iron uptake system participates in numerous key phenotypes and
thus may be integral to host infection, especially in humans.
RESULTS
C. jejuni cultured in medium containing chicken cecal or human fecal extracts
compared to medium alone exhibited comparable levels of logarithmic growth,
enhanced late-stage survival, and decreased bioﬁlm formation. Sterile pooled
chicken cecal extract from 35 chickens (chicken pool [CP]) and three unique pools of
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human fecal extracts from 9 volunteers (human pools 1, 2, and 3 [HP1, HP2, and HP3])
were prepared by dilution of cecal/fecal material in sterile H2O and sterilization by
ﬁltration (Fig. 1A). Wild-type C. jejuni strain 81-176 was grown in Mueller-Hinton
medium (MH) alone or MH supplemented with 30% CP, HP1, HP2, or HP3 to investigate
the effects of extract exposure on in vitro growth and bioﬁlm formation (Fig. 1B and C).
The 30% supplement condition was selected for these analyses based on limited extract
volume and C. jejuni sensitivity to high osmotic stress (26). C. jejuni exponential growth
rates were comparable under each condition for the ﬁrst 12 h after inoculation, with
doubling times ranging between 1.9 and 2.2 h (Fig. 1B). At 24 h, C. jejuni cells grown
in medium alone showed reduced viability, as expected under this growth condition,
while C. jejuni cells incubated in medium containing either chicken cecal or human fecal
extracts maintained signiﬁcantly higher viability (Fig. 1B). Growth in extracts did not
impact C. jejuni cell morphology (data not shown). Bioﬁlm formation was assessed for
C. jejuni exposed to medium alone, and to medium containing 10% chicken cecal or
human fecal extracts (Fig. 1C). A concentration of 10% extract was selected to conserve
extract, as preliminary testing showed no difference between levels of C. jejuni bioﬁlm
formation in medium containing 10% or 30% extracts (data not shown). After 12 h,
bioﬁlm formation in medium containing extracts was comparable to or slightly higher
than that in medium alone. However, at 24 and 36 h, C. jejuni cells grown in medium
containing extracts exhibited lower bioﬁlm abundance than cells grown in medium
alone. One exception was C. jejuni cells grown in medium containing 10% CP at 36 h,
which did not show a signiﬁcant difference. The reduced bioﬁlm formation in medium
containing extracts was not caused by poor growth, since planktonic cell concentra-
FIG 1 C. jejuni growth and bioﬁlm formation in the presence of prepared extracts. (A) The four sterile pooled extracts (chicken pool [CP] and
human pools 1, 2, and 3 [HP1, HP2, and HP3]) were prepared from 35 individual chicken cecal extracts and 9 human fecal extracts (H1C, H2, etc.,
human fecal extract numerical identiﬁer; M/F, male/female). (B) C. jejuni growth in MH, MH plus 30% CP, and MH plus 30% HP1, HP2, and HP3
as measured by dilution plating. (C) C. jejuni bioﬁlm formation over time with and without 10% extract as measured by the crystal violet assay
(top) compared to the viable planktonic cell count (bottom). Error bars represent the standard deviation from 3 replicates. Statistical analysis for
growth and bioﬁlm formation was performed using the Student’s t test with Welch’s correction and compares MH plus extract conditions (CP,
pink; HP1, light blue; HP2, medium blue; HP3, dark blue) to the MH control (black) for each time point. *, P  0.05; **, P  0.005; ***, P  0.0005;
****, P  0.0001.
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tions were comparable or higher under these conditions, similar to observations in
shaking broth noted above.
C. jejuni exposed to host intestinal extracts responded by altering the expres-
sion of metabolism and iron uptake-related genes. We used RNA sequencing to
assess the transcriptional response of C. jejuni upon exposure to extracts. C. jejuni cells
were incubated in medium alone, medium plus 30% CP, and medium plus 30% HP1,
HP2, or HP3. RNA was collected after 20 min to assess transient differences in gene
expression and after 5 h to assess adaptive homeostatic differences. Sample data from
the 20 different conditions were grouped as outlined in Table S1 in the supplemental
material, and two different evaluation conditions were analyzed in detail: (i) exposure
to medium containing extract versus medium alone (referred to as extract versus
medium—discussed in this section) and (ii) exposure to human fecal extracts versus
chicken cecal extract (referred to as human versus chicken—discussed in the next
section).
C. jejuni cells exposed to medium containing either human or chicken extracts
versus medium alone revealed 23 genes with 2-fold higher expression (Table 1) and
17 genes with 2-fold lower expression (Table 2). Of the genes showing higher
expression after exposure to extracts, 13 were related to metabolism, nutrient uptake,
and energy production (aspA, dcuA, dcuB, 0438, 0439, 0884, 0885, 1389–1391, metC,
purB-2, and 1570) (27–29), and 3 encoded hypothetical proteins with no annotated
function (0204, 0440, and 1005). Also demonstrating higher expression was a 7-gene
cluster (1649–1655) that includes a homologue of an iron transporter in Escherichia coli
(1649) (30), and p19 (1650), encoding a periplasmic iron binding protein involved in iron
transport (25, 31) (Table 1). Genes 0438 and 0439 showed the largest increase in
TABLE 1 C. jejuni genes showing higher expression (2-fold) in medium containing extract than in medium alone
Locus tag Gene name Gene product function
20 min 5 h
Fold
change P value
Fold
change P value
Metabolism, nutrient uptake,
and energy production
CJJ81176_0122 aspA Aspartate ammonia-lyase 3.2 6.13E08 2.5 4.61E05
CJJ81176_0123 dcuA Anaerobic C4-dicarboxylate membrane
transporter DcuA
2.9 2.79E09 2.5 1.31E06
CJJ81176_0438 CJJ81176_0438 Putative oxidoreductase subunit 4.5 1.97E54 11.8 8.63E149
CJJ81176_0439 CJJ81176_0439 Oxidoreductase, putative 4.4 4.54E28 12.1 2.71E80
CJJ81176_0697 dcuB Anaerobic C4-dicarboxylate membrane
transporter DcuB
2.1 3.52E08 3.1 4.10E19
CJJ81176_0884 CJJ81176_0884 Cytochrome c family protein, degenerate 2.1 2.47E08 2.9 5.25E19
CJJ81176_0885 CJJ81176_0885 Cytochrome c 2.4 5.34E10 4.1 3.16E27
CJJ81176_1389 CJJ81176_1389 DNA-binding protein 2.1 2.81E05
CJJ81176_1390 CJJ81176_1390 Reactive intermediate/imine deaminase 2.4 3.87E02
CJJ81176_1391 CJJ81176_1391 C4-dicarboxylate ABC transporter 2.5 1.31E02
CJJ81176_1392 metC Cystathionine -lyase 2.5 6.81E03
CJJ81176_1393 purB-2 Adenylosuccinate lyase 2.2 2.57E02
CJJ81176_1570 CJJ81176_1570 Anaerobic dimethyl sulfoxide reductase
chain A
2.4 8.60E03
Iron uptake
CJJ81176_1649 CJJ81176_1649 Iron permease, FTR1 family 3.2 1.19E04
CJJ81176_1650 p19 Periplasmic iron binding protein 3.8 1.01E05
CJJ81176_1651 CJJ81176_1651 Membrane protein, putative 2.9 9.05E04
CJJ81176_1652 CJJ81176_1652 ABC transporter, permease protein 3.5 6.02E05
CJJ81176_1653 CJJ81176_1653 ABC transporter, permease protein 3.9 5.62E06
CJJ81176_1654 CJJ81176_1654 ABC transporter, ATP-binding protein 4.3 1.14E06
CJJ81176_1655 CJJ81176_1655 Thioredoxin, homologue 4.2 4.84E06
Hypothetical proteins
CJJ81176_0204 CJJ81176_0204 Hypothetical protein 2.9 1.85E12 4.4 3.99E26
CJJ81176_0440 CJJ81176_0440 Conserved hypothetical protein 2.4 1.69E11 2.1 1.12E08
CJJ81176_1005 CJJ81176_1005 Membrane protein, putative 2.1 1.11E03
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expression both at 20 min (4.5- and 4.4-fold, respectively) and 5 h (11.8- and 12.1-fold,
respectively). These genes (originally annotated by NCTC11168 locus tags cj0414 and
cj0415) are required for gluconate dehydrogenase activity, allowing C. jejuni to use
gluconate as an electron donor (32). Of the 17 genes showing reduced expression after
incubation in medium supplemented with extracts in comparison to medium alone,
one was a cell surface adhesin (peb3), 9 were involved in metabolism, nutrient uptake,
and energy production (gltB, gltD, 0580, 0581, 0685, 0912, 0941, 0942, and 1386), 2 were
involved in oxidative stress (herA and 1656), and 4 encoded hypothetical proteins with
no annotated function (1006, 1184, 1185, and 1657) (Table 2). The gene exhibiting the
greatest decrease during incubation in extracts was peb3 at both 20 min (3.0-fold) and
5 h (6.2-fold). It encodes a cell surface glycoprotein adhesin that also imports phos-
phorylated compounds (33). PEB3 is a major antigenic protein during human infection,
so rapid downregulation of this gene may be advantageous to host colonization (34,
35). A list of differentially expressed genes in C. jejuni cultured in medium with either
human or chicken extracts in comparison to medium alone at each sampling time is in
Table S2 in the supplemental material, and a Venn diagram of these genes is presented
in Fig. S1 in the supplemental material.
C. jejuni exposed to human fecal extracts versus chicken cecal extract had
higher expression of iron uptake and formate dehydrogenase genes. As noted
above, we also compared C. jejuni gene expression during growth in medium supple-
mented with human fecal extracts to expression during growth in medium supple-
mented with chicken cecal extract. This identiﬁed 2 genes with 2-fold higher expres-
sion after 20 min and 12 genes with higher expression after 5 h (Table 3). No genes
showing reduced expression were identiﬁed. The 2 genes with higher expression in
human extracts after 20 min of exposure (fdhT, 2.4-fold; fdhU, 2.9-fold) increased further
at 5 h (6.4- and 3.3-fold higher, respectively). FdhTU is involved in formate dehydro-
genase activity and contributes to the invasion and intracellular survival of C. jejuni in
intestinal epithelial cells (36, 37). The remaining 10 genes with 2.5- to 3.4-fold higher
TABLE 2 C. jejuni genes showing lower expression (2-fold) in medium containing extract versus medium alone
Locus tag Gene name Gene product function
20 min 5 h
Fold
change P value
Fold
change P value
Adhesin
CJJ81176_0315 peb3 Major antigenic peptide PEB3 3.0 2.93E06 6.2 2.33E17
Metabolism, nutrient uptake,
and energy production
CJJ81176_0033 gltB Glutamate synthase, large subunit 2.1 5.06E04
CJJ81176_0035 gltD Glutamate synthase, small subunit 2.1 8.27E31
CJJ81176_0580 CJJ81176_0580 C4-dicarboxylate ABC transporter 3.4 5.77E21
CJJ81176_0581 CJJ81176_0581 Amidohydrolase 2.0 3.04E07
CJJ81176_0685 CJJ81176_0685 Di/tripeptide transporter 2.9 1.81E26
CJJ81176_0912 CJJ81176_0912 Amino acid carrier protein 2.5 1.88E08
CJJ81176_0941 CJJ81176_0941 Sodium:alanine symporter 2.5 7.05E07
CJJ81176_0942 CJJ81176_0942 Sodium:alanine symporter 2.6 9.79E07
CJJ81176_1386 CJJ81176_1386 Fumarate reductase 2.6 4.37E02
Chemotaxis
CJJ81176_0109 CJJ81176_0109 Methyl-accepting chemotaxis protein 2.4 1.13E03
Oxidative response
CJJ81176_0266 herA Hemerythrin 2.1 2.08E02
CJJ81176_1656 CJJ81176_1656 Thioredoxin family protein 2.0 2.88E02
Hypothetical proteins
CJJ81176_1006 CJJ81176_1006 Hypothetical protein 2.3 1.43E03
CJJ81176_1184 CJJ81176_1184 Hypothetical protein 2.5 3.58E04
CJJ81176_1185 CJJ81176_1185 Hypothetical protein 2.6 9.42E04
CJJ81176_1657 CJJ81176_1657 Hypothetical protein 2.6 5.54E31 2.7 1.72E32
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expression after 5 h are known or hypothesized to be involved in iron uptake and/or
utilization (Table 3). The cfbpA, ceuB, and chuC genes encode parts of three different
C. jejuni iron uptake systems: cfbpA encodes the periplasmic iron binding protein for the
ferri-transferrin uptake system (38), ceuB encodes the periplasmic permease for the
ferri-enterochelin uptake system (39), and chuC encodes part of the ABC transporter
system for the heme uptake system (40, 41). None of the other components in these
iron uptake systems showed higher expression in human fecal extracts versus chicken
cecal extract (41). The remaining 7 genes were 1649–1655, which were also more highly
expressed in C. jejuni cells exposed to extracts in comparison to those exposed to
medium alone and are described in more detail in the following sections.
Human fecal extracts contain higher total iron content than chicken cecal
extract. Since the majority of the genes more highly expressed during growth in
human fecal extracts were related to iron uptake, we hypothesized that cells grown in
human fecal extracts were more iron starved than cells growing in chicken cecal extract.
Quantiﬁcation of the total iron present in extracts in all its forms was carried out using
inductively coupled plasma mass spectrometry (ICP-MS). Unexpectedly, human extracts
were found to contain approximately four times more iron than the chicken cecal
extract (Fig. 2), suggesting the iron present is tightly chelated and requires specialized
uptake systems.
Homologues of 1649–1655 are widely conserved in the bacterial kingdom. The
increased expression of the 1649–1655 genes suggested that they are important in the
C. jejuni response to extracts, especially human fecal extracts. The Escherichia coli
homologue (FetM) of 1649 is a ferrous iron permease (30), and the periplasmic protein
1650 (P19) has been characterized as an iron transporter in C. jejuni (25), E. coli (30),
TABLE 3 C. jejuni genes showing higher expression in medium containing human fecal extract in comparison to medium containing
chicken cecal extract
Locus tag Gene name Gene product function
20 min 5 h
Fold
change P value
Fold
change P value
Respiration
CJJ81176_1492 fdhT Membrane protein, putative 2.9 8.27E03 6.4 1.29E10
CJJ81176_1493 fdhU Conserved hypothetical protein 2.4 3.00E02 3.3 8.96E05
Iron uptake
CJJ81176_0211 cfbpA Iron ABC transporter, periplasmic iron-binding protein 2.8 1.56E02
CJJ81176_1351 ceuB Enterochelin ABC transporter, permease protein 2.9 1.58E02
CJJ81176_1603 chuC Hemin ABC transporter, ATP-binding protein, putative 3.4 2.63E02
CJJ81176_1649 CJJ81176_1649 Iron permease, FTR1 family 2.7 3.44E03
CJJ81176_1650 p19 Periplasmic iron binding protein 2.9 2.05E03
CJJ81176_1651 CJJ81176_1651 Membrane protein, putative 2.6 7.86E03
CJJ81176_1652 CJJ81176_1652 ABC transporter, permease protein 2.7 7.86E03
CJJ81176_1653 CJJ81176_1653 ABC transporter, permease protein 2.7 7.86E03
CJJ81176_1654 CJJ81176_1654 ABC transporter, ATP-binding protein 2.5 1.58E02
CJJ81176_1655 CJJ81176_1655 Thioredoxin, homologue 2.5 3.59E02
FIG 2 Iron concentration of pooled chicken and human extracts. The iron concentration of each pooled
extract was measured using ICP-MS. Error bars represent the standard deviation from 2 duplicate tests.
The signiﬁcance was calculated by ANOVA. ***, P  0.005.
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Bordetella (42), and Yersinia pestis (43). However, no prevalence or functional studies
have been reported on the downstream genes (1651–1656) or homologues. As deter-
mined by conserved domain analyses and genome annotation, 1651–1655 were pre-
dicted to consecutively encode an inner membrane protein (1651), two inner mem-
brane permeases (1652 and 1653), a cytoplasmic ATPase (1654), and a periplasmic
thioredoxin (1655) (Fig. 3A). Also, one downstream gene (1656) overlaps with 1655 by
35 bp, encodes a second putative periplasmic thioredoxin (1656), and is assumed to be
part of the same gene cluster (Fig. 3A). This set of 8 genes (1649–1656) is carried directly
downstream of a Fur box and has one putative primary transcription start site located
54 bases upstream of the 1649 start codon, suggesting that these genes are transcribed
as part of an operon (Fig. 3A) (44). The gene upstream of 1649 (1648, encoding a
hypothetical protein) ends 350 bp before the start of 1649, and the gene downstream
of 1656 (1657, also encoding a hypothetical protein) is carried on the opposite strand.
Each of these ﬂanking genes has its own primary transcription start sites and is thus
unlikely part of the proposed 1649–1656 operon (44).
Protein BLAST analyses showed that the 1649–1656 system is widely conserved in
the bacterial kingdom. Components of the system are found in 22 of 28 fully sequenced
Campylobacter species. Of the species lacking components of this system, C. avium,
C. helveticus, C. hepaticus, and C. ornithocola have not been associated with human
FIG 3 The 1649–1656 operon in C. jejuni and other bacterial species. (A) Proposed operon structure in C. jejuni wild-type strain 81-176, including ﬂanking genes
1648 and 1657. TSS, transcription start site. (B) Homologues found within representative bacterial species identiﬁed with blastp are shown to scale. The colored
bars correspond to the genes described in the legend. Red and pink circles designate that the organism is associated with human disease or colonization,
respectively. Organisms listed in alphabetical order: Actinobacillus succinogenes 130Z, Aggregatibacter actinomycetemcomitans NUM4039, Biﬁdobacterium
kashiwanohense PV20-2, Brenneria goodwinii, Campylobacter coli RM4661, Campylobacter fetus 82-40, Campylobacter jejuni 81-176, Campylobacter lari RM2100,
Citrobacter koseri ATCC BAA-895, Escherichia coli VR50(pVR50B), Filifactor alocis ATCC 35896, Flexistipes sinusarabici DSM 4947, Frischella perrara PEB0191,
Haemophilus parainﬂuenzae T3T1, Jonquetella anthropi DSM 22815, Klebsiella pneumoniae B2(pB2-A/C), Leminorella grimontii ATCC 33999 ( DSM 5078),
Mobiluncus curtisii ATCC 43063, Paracoccus halophilus, Parascardovia denticolens DSM 10105, Parvimonas micra KCOM 1535, Pasteurella multocida Pm70,
Pectobacterium carotovorum PC1, Pelosinus sp. strain UFO1, Rhodospirillum rubrum ATCC 11170, Salmonella enterica serovar Typhimurium T000240, Selenomonas
sputigena ATCC 35185, Shigella dysenteriae 80-547(p80-547), Spirochaeta thermophila DSM 6578, Sulfurospirillum multivorans DSM 12446, Treponema sp. strain
OMZ 838, Wolinella succinogenes DSM 1740, and Yersinia pestis CO92.
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illness, and C. lanienae and C. sputorum are infrequently found by PCR in stools of both
healthy and diarrhetic humans (45, 46). We also identiﬁed representative homologues
of 1649–1656 in 33 phylogenetically diverse bacterial species with available complete
genome sequences (Fig. 3B; see Table S3 in the supplemental material). Homologous
gene products were most commonly found in members of the Proteobacteria, but were
also present in Actinobacteria, Firmicutes, Deferribacteres, Spirochaetes, and Synergistes.
Genes making up the operon were chromosomally carried in 30 of the 33 bacterial
species and on plasmids in Escherichia, Klebsiella, and Shigella. Homologues of 1649–
1656 were found in both Gram-positive and Gram-negative bacteria colonizing and
infecting humans (22 out of 33 species identiﬁed), cows (Actinobacillus succinogenes
and Wolinella succinogenes [47, 48]), honey bees (Frischella perrara [49]), and plants
(Brenneria goodwinii and Pectobacterium carotovorum [50, 51]), as well as environmental
isolates from water (Flexistipes sinusarabici, Paracoccus halophilus, and Rhodospirillum
rubrum [52–54]), soil (Pelosinus sp. and Sulfurospirillum halorespirans [55, 56]), and
thermal sites (Spirochaeta thermophila [57]). With respect to human colonizers, most
bacterial species identiﬁed were associated with diseases such as gastroenteritis (e.g.,
Campylobacter jejuni), periodontal disease (e.g., Filifactor alocis [58]), urinary tract
infection (e.g., Leminorella grimontii [59]), vaginosis (e.g., Mobiluncus curtisii [60]), and
spondylodiscitis (e.g., Parvimonas micra [61]).
The organization of the operon and predicted gene products in each of the 33
bacterial species were examined. All 33 species carried homologues of the ﬁrst six
genes (1649–1654) with the same gene order, similar gene lengths, and comparable
spacing between genes (Fig. 3B). While most members of the Proteobacteria carried a
predicted thioredoxin gene as the seventh gene in the cluster, members of the
Actinobacteria, Firmicutes, Spirochaetes, and Synergistetes encoded a predicted ﬂavin
mononucleotide (FMN) binding protein. Although the thioredoxins may not be directly
involved in iron uptake, both thioredoxins and FMN binding proteins can serve as a
source of periplasmic or extracytoplasmic reduction potential to reduce ferric iron to
the ferrous form for transport into the cell. In Proteobacteria without a thioredoxin
encoded by the eighth gene, a gene coding for either a cytochrome or a hypothetical
protein was present. The high genetic conservation of this system in multiple bacterial
phyla suggests that, minimally, the ﬁrst 7 gene products form one functional system,
which is further investigated in the following sections.
The 1651–1656 genes are involved in iron acquisition. To determine if the
1651–1656 genes were involved in iron acquisition similar to 1649 and p19, deletion
(1651–1656) and complemented (1651–1656C) C. jejuni strains were constructed
(Fig. 4). The p19 (1650) deletion mutant (p19) and complemented (p19C) strains were
used as controls since P19 is well conserved and is known to be involved in iron
transport (25). The p19 and 1651–1656 mutants each exhibited lower growth rates
than the wild-type 81-176 strain or the corresponding complements during growth in
MH medium, but reached comparable ﬁnal viable cell concentrations at 32 h (Fig. 4D).
Iron depletion by addition of 20 M desferroxamine (DFO), an iron chelator, resulted in
a similar initial growth rate for the 1651–1656 mutant, a modestly reduced initial
growth rate for the p19 mutant, and signiﬁcantly reduced viability for both mutants
after 12 h compared to the wild-type and complemented strains (Fig. 4E). Growth rates
in MH for each mutant could be restored to wild-type and complement levels by
supplementation with 100 M iron(III) citrate (Fig. 4F).
The 1649–1656 iron uptake system is involved in the C. jejuni response to acid,
streptomycin, and H2O2-mediated oxidative stress. C. jejuni wild-type strain 81-176,
the p19 and 1651–1656 mutant strains, and the respective complements were
exposed to acid (pH 5), antibiotic, and oxidative stress (1 mM H2O2) conditions to
determine whether this iron uptake system is important for C. jejuni stress survival
(Fig. 5). To test acid tolerance, cells were inoculated into MH at neutral pH or MH at pH 5
with and without supplementation with 100 M iron(III) citrate and grown for 24 h. The
p19 and 1651–1656 mutants exhibited a 2- to 3-log reduction in growth at pH 5 in
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comparison to neutral pH, while growth of the wild-type and complement strains was
unaffected by the pH 5 condition (Fig. 5A). The acid sensitivity phenotype of the
mutants was observed in media both with and without 100 M iron(III) citrate supple-
mentation; however, iron supplementation partially restored growth of the mutants
(Fig. 5A). Iron is more soluble at lower pH, which may contribute to the improved
growth of mutants in acidic medium supplemented with iron(III) citrate.
To assess whether this iron uptake system was required for antibiotic resistance, the
MICs of different antibiotics representing multiple classes (aminoglycosides, ampheni-
cols, -lactams, cationic peptides, ﬂuoroquinolones, and macrolides) were screened for
wild-type and 1651–1656 deletion mutant strains using standard doubling dilution
assays. Most classes showed 2-fold differences from wild type, except aminoglyco-
sides, the most notable of which was streptomycin (STM) (data not shown). To test STM
susceptibility in more depth, cells were inoculated into MH or MH supplemented with
100 M iron(III) citrate containing no STM or doubling dilutions of STM from 0.02 to
16 g/ml and grown for 48 h. In iron-unsupplemented MH, the MICs observed for the
1651–1656 (2 g/ml) and p19 (2 g/ml) mutants were 8 times lower than the STM
MIC for the wild-type and complemented strains (16 g/ml). Supplementation of MH
with excess iron restored the MICs of the 1651–1656 and p19 mutants (8 and
16 g/ml, respectively) to wild-type levels (16 g/ml). To expand our analysis of STM
sensitivity, cell densities (optical density at 600 nm [OD600]) were measured under
increasing concentrations of STM both with and without iron supplementation (Fig. 5B
and C). A bimodal growth phenotype was observed for wild-type and complemented
strains both with and without iron supplementation (Fig. 5B and C). This bimodal
phenotype consisted of STM-sensitive growth between 0 and 1 g/ml, where cell
density decreased rapidly from 100% to 40% compared to growth with no STM, and
then STM-tolerated growth between 1 and 8 g/ml. Unlike the wild-type and comple-
mented strains, the 1651–1656 and p19 mutants exhibited monomodal growth
FIG 4 Construction of the 1651–1656 mutant and complemented strains (1651–1656C) and their growth in iron-limiting and iron-supplemented media
compared to the p19 and p19C strains. (A) The wild-type 1649–1656 gene locus, including the upstream and downstream genes as well as the 16S rRNA region
used for complementation. TSS, transcription start site; blue box, Fur binding sequence (Fur box). (B) The 1651–1656 mutant was constructed by replacing
1651–1656 with a kanamycin resistance cassette (Kmr). The region deleted is indicated. (C) Using the integrative vector pRRC (85), the 1651–1656 gene cluster
was inserted into a noncoding region between the 16S rRNA and tRNA-Ala to generate the 1651–1656C complement. The 1651–1656 genes in the
complemented strain are under the control of a chloramphenicol promoter (Pcm) upstream of the chloramphenicol resistance marker (Cmr) used for selection.
Growth over time of the C. jejuni wild-type (black solid line), 1651–1656 (red dotted line), 1651–1656C (red solid line), p19 (blue dotted line), and p19C (blue
solid line) strains in MH (D), iron-depleted MH containing 20 M DFO (E), and iron-supplemented MH containing 100 M iron(III) citrate (F) was measured by
dilution plating. Error bars represent the standard deviations from 3 replicates from a total of 3 experiments. Statistical comparison of the 1651–1656 and p19
mutants versus the wild-type control was performed using the Student’s t test with Welch’s correction, where indicated. ****, P  0.0001.
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under increasing STM concentrations in iron-limited MH, with both strains becoming
undetectable at 2 g/ml STM (Fig. 5B). Iron supplementation restored bimodal growth
for both mutants (Fig. 5C).
To examine if this operon had an effect on oxidative stress, wild-type strain 81-176,
the p19 and 1651–1656 mutants, and their respective complements were grown in
medium alone or medium supplemented with 100 M iron(III) citrate for 6 h, at which
time H2O2 was added to a ﬁnal concentration of 1 mM. Cell viability was monitored at
FIG 5 The role of 1651–1656 in C. jejuni survival under acid, oxidative (H2O2), and antibiotic (streptomycin) stress in
comparison to P19. (A) Acid stress: comparison of growth in MH or in MH at pH 5 with and without 100 M iron(III) citrate
supplementation after 24 h (B and C) of antibiotic stress. Shown is the percentage of cell growth (based on OD600) in doubling
dilutions of streptomycin compared to the no-streptomycin control when incubated in MH (B) and MH supplemented with
100 M iron(III) citrate (C) for 48 h. (D and E) Oxidative stress. Shown is the viability of C. jejuni strains over 6 h after H2O2
addition in MH alone (D) or MH supplemented with iron(III) citrate (E). C. jejuni strains are shown as the wild type (black solid
line), the 1651–1656 mutant (red dotted line), the 1651–1656C complement (red solid line), the p19 mutant (blue dotted
line), and the p19C complement (blue solid line). Error bars represent the standard deviation from 3 replicates from a total of
3 experiments. Statistical comparison of the 1651–1656 and p19 mutants to the wild-type 81-176 strain was performed
using Student’s t test with Welch’s correction. ***, P  0.0005; ****, P  0.0001.
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3 h and 6 h after H2O2 addition. The mutants were more resistant to H2O2 stress than
the wild-type or complemented strains when grown in MH and in iron-supplemented
MH, remaining viable at 3 h and 6 h post-H2O2 addition, whereas the wild-type and
complemented strains were no longer recoverable by 3 h (Fig. 5D and E).
The 1649–1656 system is required for optimal iron acquisition from human
and chicken extracts. To determine whether the 1649–1656 system is involved in
acquisition of iron found in extracts, we grew the wild-type and mutant strains in
iron-limited MH (15 M DFO) or iron-limited MH supplemented with 10% chicken or
human extracts. Growth in MH and iron-limited MH supplemented with 10 M iron(III)
citrate was included as a control. The DFO concentration of 15 M was selected to
allow optimal C. jejuni responsiveness to iron supplementation based on optimization
testing, and the iron(III) citrate concentration of 10 M was selected to approximate
the maximum amount of iron expected in the extract samples. After 24 h, wild-type and
complemented C. jejuni strains showed reduced growth under iron restriction in
comparison to the MH control, which was rescued by supplementation with human
extracts or iron(III) citrate (Fig. 6A; see Fig. S2A to F in the supplemental material).
Notably, supplementation with chicken cecal extract was not sufﬁcient to restore
wild-type growth at 24 h, but did improve wild-type growth at 48 h in comparison to
iron-limited medium alone (Fig. 6A; Fig. S2C and F). These results suggest that wild-type
C. jejuni can utilize iron present in the extracts and that more accessible iron is present
in human fecal than in chicken cecal extracts. The p19 and 1651–1656 deletion
strains were also deﬁcient for growth in iron-restricted MH. However, supplementation
with human fecal extracts did not restore bacterial growth to levels observed in MH
FIG 6 Growth of C. jejuni strains in iron-depleted medium and with extract supplementation. Shown is
C. jejuni growth in control medium (MH; black), iron-limited medium (MH plus 15 M DFO [gray]), and
iron-limited medium supplemented with extracts (10% CP/HP1/HP2/HP3 [CP, pink; HP1, light blue; HP2,
medium blue; HP3, dark blue) or iron(III) citrate (10 M [black dashed/striped). (A) Growth of wild-type
C. jejuni over 48 h. Statistical signiﬁcance was calculated in comparison to the MH control. (B) Growth of
wild-type, deletion mutant, and complemented strains at 24 h. Statistics were calculated in comparison
to wild-type strain 81-176 for each growth condition. For both panels A and B, P values are as follows:
*, P  0.05; **, P  0.005; ***, P  0.0005; ****, P  0.0001.
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alone or iron-limited MH supplemented with iron(III) citrate (Fig. 6B; Fig. S2A to F). This
demonstrated that the 1649–1656 system is required for optimal acquisition of iron
from human fecal extracts.
DISCUSSION
The ability of C. jejuni to colonize both chicken ceca and human large intestines to
high concentrations (7, 8, 12) is reﬂected in this study, where supplementation of MH
with extracts prolonged C. jejuni survival in broth culture. The lower bioﬁlm formation
in extracts, which may provide additional nutrients, is consistent with studies indicating
that C. jejuni bioﬁlm formation is less abundant in richer media (62). We collected
intestinal extracts using water as a diluent, which preferentially extracts polar com-
pounds such as amino acids, carbohydrates, alcohols, and short-chain fatty acids (63).
Accordingly, C. jejuni cells exposed to these extracts responded by modulating expres-
sion of many genes related to metabolism, nutrient uptake, energy production, and
chemotaxis. Other diluents used to prepare fecal extracts, such as methanol, acetoni-
trile, and ethyl acetate, preferentially extract aromatic compounds and lipids (16, 19,
63, 64). Future assessments may beneﬁt from using different diluents to determine
whether additional biologically active metabolites also impact pathogen response.
In this study, C. jejuni exposed to extracts, and in particular human fecal extracts,
showed higher expression of genes related to iron uptake and utilization than C. jejuni
in medium alone. A recent study of C. jejuni gene expression in human feces postcolo-
nization also found that genes involved in iron acquisition were more highly expressed:
notably, 6 out of 8 genes in the 1649–1656 operon were identiﬁed (65). Iron is an
essential micronutrient for most organisms, with many producing high-afﬁnity iron
chelating proteins and siderophores to scavenge iron. C. jejuni does not produce
siderophores, but does possess at least 5 distinct systems to import iron from exoge-
nous chelators (41). These systems transport iron bound to enterobactin (CfrA, CfrB,
CeuBCDE [66, 67]), heme (ChuABCDZ [40]), lactoferrin/transferrin (CtuA, CfbpABC, and
ChaN [68]), ferrous ions (FeoB [69]), and potentially bound to rhodotorulic acid
(Cj16581663 in strain 11168, which are homologues of 1649–1654 in strain 81-176
[31]). C. jejuni globally regulates expression of the majority of its iron uptake systems
through the iron-responsive Fur regulator (67, 70, 71). The speciﬁc increase in 1649–
1655 expression during exposure to human extracts and during human colonization,
rather than a global response to low iron availability, suggests that other regulatory
mechanisms target this system in addition to the Fur-based response. Furthermore,
1656, which shares an overlapping reading frame with 1655, actually showed a small
decrease in expression during C. jejuni exposure to extracts, which may suggest even
more complex regulation mechanisms at play.
It remains to be determined why the 1649–1655 operon was more highly expressed
during C. jejuni exposure to extracts, especially human extracts, which contain more
iron than the chicken cecal extracts. One hypothesis is that the iron present in the
extracts, particularly human fecal extracts, is chelated to a compound that is speciﬁcally
recognized by this iron uptake system. Indeed, in medium depleted of iron, supple-
mentation with human extracts was able to fully restore growth of wild-type C. jejuni
but not of the p19 or 1651–1656 mutant. The 1649–1656 system was suggested to
import iron bound to rhodotorulic acid, a fungal hydroxamate siderophore (reported as
unpublished data in reference 31). However, other studies show that C. jejuni is unable
to utilize iron bound to rhodotorulic acid for growth (72, 73); therefore, other chelators
must be considered.
In Yersinia pestis, mutations in fetMP (homologues of C. jejuni 1649 and p19) resulted
in iron-deﬁcient growth that could only be restored when the downstream genes y2367
to y2362 (homologues of C. jejuni 81-176 genes 1651–1655) were included in the
complementation strain (43). Here, genes downstream of p19 (1651–1656) were also
required for C. jejuni growth under iron-restricted conditions. Furthermore, the wide-
spread distribution and genetic conservation of the 1649–1656 cluster in bacteria with
a variety of host preferences (e.g., humans, plants, cows, and bees) and ecologic niches
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(e.g., freshwater, seawater, soil, and thermal site) suggests that this entire system is
used for iron uptake in many contexts. An analysis of the diversity and phylogenetic
evolution of this iron uptake system, together with follow-up genetic and biochemical
analyses, will allow better understanding of its role in bacteria.
Iron uptake in C. jejuni may be generally related to acid tolerance and antibiotic
survival. Transcriptomic and proteomic studies have shown that this iron uptake
system, in addition to several other iron uptake genes (cfbpA/B, ceuE, and chuZ), was
more highly expressed upon C. jejuni exposure to acid stress (74, 75). In addition,
deletion of fur increased C. jejuni sensitivity to acidic conditions (76). Paradoxically,
however, C. jejuni acid sensitivity caused by deletion of p19, 1651–1656, and fur was
independent of iron availability in the growth medium, further indicating that addi-
tional regulatory mechanisms must be considered. Variability in iron availability and
disturbance of bacterial iron homeostasis have also been shown to impact antibiotic
efﬁcacy in various bacteria (77). However, since the C. jejuni 81-176 strain has not been
reported to carry streptomycin resistance genes, the mechanism of streptomycin
tolerance and potential contribution of iron to this extended tolerance are unknown.
The interplay between acid stress and iron homeostasis remains an interesting avenue
for future research. Additional information pertaining to how C. jejuni responds to these
stresses and the implications for resistance to streptomycin can be gained from
genomewide expression analyses of C. jejuni under a combination of acid and iron
stresses.
Unexpectedly, the 1649–1656 system adversely affected the C. jejuni response to
H2O2 independent of the addition of iron. C. jejuni responds to oxidative stress and iron
limitation by inducing expression of a common subset of genes (e.g., katA, sodB, and
ahpC) that are controlled by both the Fur and PerR regulons (78, 79). Thus, loss of the
1649–1656 iron uptake system may cause constitutive cellular stress that elevated the
baseline expression of genes contributing to oxidative stress tolerance. Alternatively,
the presence of iron and copper binding proteins in the 1649–1656 systemmay directly
render C. jejuni more sensitive to H2O2-mediated cell death by formation of highly
reactive and damaging intermediates upon exposure to H2O2 (25, 80). Exploring
whether related conditions such as nitrosative stress yield similar results would be
interesting, as would examining the effects of combining the 1651–1656 or p19
mutations with mutations in genes known to be required for oxidative stress survival.
An updated model of the 1649–1656 iron uptake system is proposed based on
bioinformatic analyses, showing the presence of signal peptides, transmembrane re-
gions, and protein domains (Fig. 7). The 1649–1656 gene products are hypothesized to
form one functional system based on comparable phenotypes observed between the
1651–1656 and p19 mutants and conservation of the gene cluster in multiple
bacterial phyla. Of note, the 1651 membrane protein has a periplasmic DUF2318
domain, encoding a conserved CxxC-x(13)-CxxC-x(14,15)-C motif (see Fig. S3A and B
in the supplemental material). Conserved cysteines with regular spacing are often
observed in iron-sulfur cluster binding domains, such as those seen in the Fer2 and
Fer4 families (Fig. S3C and D). Furthermore, we found that genes encoding
DUF2318-containing proteins almost always mapped to gene clusters with homo-
logues of 1649–1656 in different bacterial species, indicating association with this
bacterial iron uptake system. Ongoing experiments aimed toward single gene deletions
and domain or residue speciﬁc substitutions should help determine the identity of
transported substrates, protein-protein interactions, and mechanism(s) of iron trans-
port.
In sum, this study is the ﬁrst to compare the bacterial transcriptional and functional
responses to gut extracts from a disease-susceptible host (humans) and a zoonotic host
(chicken). RNA sequencing identiﬁed genes that may be important for C. jejuni to
colonize both chickens and humans, with subsequent biological analyses demonstrat-
ing that the 1649–1656 iron uptake system was necessary for C. jejuni growth under
iron-depleted conditions, impacted growth and survival under speciﬁc stress-related
conditions, and was required for acquisition of iron from human fecal extracts. Given
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the system’s conservation in a wide range of bacteria, the majority of which colonize
and infect humans, this work should be broadly relevant to the general bacteriology
and pathogenesis communities as well. Collectively, we showed that investigation of
pathogen gene expression in response to exposure to the host metabolome, together
with follow-up genotypic and phenotypic analyses, is not only an informative method
of studying host-pathogen interactions but should improve our understanding of the
mechanisms employed by pathogens to cause disease.
MATERIALS AND METHODS
Ethics statement. Written and informed consent was obtained from all human fecal sample donors
as described in ethics application H14-00859, which was approved by the University of British Columbia
Clinical Research Ethics Board in Vancouver, Canada.
Bacterial strains and growth conditions. C. jejuni strain 81-176, a pathogenic and common
laboratory reference strain, was used in this study (9). The C. jejuni 1651–1656 mutant strain and
corresponding 1651–1656C complemented strain were constructed as described in Text S1 in the
supplemental material, using primers listed in Table S4 in the supplemental material. The p19 deletion
and complemented (p19C) strains were obtained from reference 25. C. jejuni strains were grown in MH
(Oxoid) broth or agar (1.5% [wt/vol]). MH was supplemented with antibiotics where appropriate:
vancomycin (V; 10 g/ml), trimethoprim (T; 5 g/ml), kanamycin (Km; 50 g/ml), and chloramphenicol
(Cm; 20 g/ml). Agar plates and standing cultures were incubated at 38°C under microaerobic and
capnophilic conditions (12% CO2 and 6% O2 in N2) in a Sanyo tri-gas incubator. Shaking broth cultures
(including 15- to 18-h overnight cultures) were incubated microaerobically in airtight containers with the
Oxoid CampyGen atmosphere generation system at 38°C and shaken at 200 rpm. Cell concentration was
measured by dilution plating; the limit of detection for this method is 103 CFU/ml. Escherichia coli strain
DH5 (Invitrogen) was used for cloning. E. coli was grown aerobically at 37°C and shaken at 200 rpm in
Luria-Bertani broth (LB; Sigma) or incubated aerobically at 37°C on LB agar (1.5% [wt/vol]) supplemented
with Cm (20 g/ml) and Km (50 g/ml) for selection, as required.
FIG 7 Model of the C. jejuni 1649–1656 iron uptake system. We hypothesize that this iron acquisition
system imports iron (yellow stars) that is bound to a speciﬁc, but as yet unidentiﬁed, chelator (light blue
hexagons). Gray hexagons represent other iron chelators. Since the gene cluster does not appear to
encode an outer membrane receptor, Chan et al. suggested that iron is transported across the outer
membrane by an as yet unidentiﬁed receptor (gray box) before binding to P19 (dark blue) in the
periplasm (25). During iron uptake, iron-bound P19 may interact with the periplasmic metal binding
domains of 1651 (brown), followed by an iron reduction step involving the 1655 and 1656 thioredoxins
(light and dark green), prior to being transported into the cytoplasm via the 1649 inner membrane
transporter (black). The substrates transported by the 1651 membrane protein and the 1652 and 1653
permeases (pink and red), with the help of the 1654 ATPase (purple), are unknown. We hypothesize that
the chelated form of iron acquired by this system is more abundant in human than in chicken intestinal
environments.
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Growth and bioﬁlm formation in extracts. Human fecal and chicken cecal extracts were prepared
as described in Text S1. For liquid growth cultures, overnight log-phase C. jejuni cells were inoculated at
an OD600 of 0.005 in a ﬁnal volume of 1 ml in MH supplemented with trimethoprim and vancomycin
(MH-TV) or MH-TV plus 30% extract. MH-TV plus 30% extract conditions were prepared by combining
0.5 ml of 2 MH-TV containing C. jejuni at an OD600 of 0.01, 0.3 ml of extract (CP, HP1, HP2, or HP3), and
0.2 ml of sterile ultrapure H2O (0.5 ml for the control MH-TV condition). Cultures were incubated
microaerobically at 38°C and shaken. The cell concentration was measured by dilution plating at the
indicated times. For bioﬁlm formation, overnight log-phase C. jejuni cells were inoculated at an OD600 of
0.02 into 1 ml of MH-TV or MH-TV containing 10% extract (CP, HP1, HP2, HP3, or H2O for the control) in
borosilicate glass tubes. The cultures were incubated microaerobically at 38°C without agitation. The
planktonic cell concentration was measured by dilution plating 20 l of culture sampled from 2 mm
below the liquid surface. The bioﬁlms were quantiﬁed as detailed in Text S1. Experiments were
performed in triplicate.
RNA preparation. C. jejuni overnight cultures were reinoculated into fresh MH-TV broth at an OD600
of 0.04 and incubated microaerobically shaking at 38°C for 4 to 5 h in order to obtain optimal log growth
(approximate OD600 of 0.2). C. jejuni cells were inoculated into MH-TV or MH-TV plus 30% extract (CP, HP1,
HP2, or HP3) to a ﬁnal volume of 1 ml at an OD600 of 0.25 for the 20-min conditions and OD600 0.06 for
the 5-h conditions in order to ensure comparable numbers of cells during harvest and RNA preparation.
RNA was extracted from these 10 independent conditions performed in duplicate on separate days as
outlined in Text S1. RNA from all samples was extracted by adding 1:10 (vol/vol) stop solution (5% phenol
in ethanol) and was extracted as described previously (81). Samples were shipped to the Wellcome Trust
Sanger Institute (WTSI), and RNA was sequenced and analyzed as described in Text S1.
Total iron content of extracts. ICP-MS was used to measure the iron content in human fecal and
chicken cecal extracts. Brieﬂy, 0.5 ml each of CP, HP1, HP2, and HP3 was added in duplicate into
microcentrifuge tubes and dried overnight using a SpeedVac concentrator (DNA 120; Thermo) at low
power. Samples were then analyzed using ICP-MS. Brieﬂy, samples were digested in 1% nitric acid
and heated in a closed Savillex vessel using a hot plate. Scandium (Sc) and indium (In) at 100 ppb
were added as internal standards. ICP-MS was conducted using the PerkinElmer NexIon 300D ICP-MS
instrument.
Protein domains and homologues. The Simple Modular Architecture Research Tool (SMART) in
Genomic mode was used to determine protein domains, signal peptides, and PFAM domains for the
amino acid sequences of 1649–1656 (http://smart.embl.de/) (82). Protter was used to visualize the
protein placement in two-dimensional (2D) space (83). Homologues of 1649–1656 were identiﬁed using
the NCBI online database with the blastn and blastp suites. To identify homologues in non-
Campylobacter organisms, the “Campylobacter (taxid: 194)” group was excluded, and fully sequenced
and annotated genomes of bacteria from each unique genus listed were downloaded from GenBank and
visualized using Artemis. The amino acid sequences for each protein were aligned using MUSCLE and
assessed for homology using MEGA 7.0.21 and BioEdit Sequence Alignment Editor, and conserved
residues were visualized using the online tool Skylign (http://skylign.org/).
Measuring growth under iron depletion, acid, streptomycin, and H2O2 stresses. Log-phase
C. jejuni cells of the 81-176, 1651–1656, 1651–1656C, p19, and p19C strains from 15- to 18-h overnight
cultures were inoculated at an OD600 of 0.005 into 3 ml of medium unless otherwise indicated. For
growth under iron-depleted versus replete conditions, cells were inoculated into MH (unsupplemented),
MH containing 20 M ferric iron chelator DFO (iron poor), or MH supplemented with 100 M iron(III)
citrate (iron rich). For H2O2 stress, cells were inoculated into MH or MH plus 100 M iron(III) citrate and
incubated for 6 h, and then H2O2 (Sigma) was added to a ﬁnal concentration of 1 mM H2O2. For acid
stress, cells were inoculated into MH or MH at pH 5, prepared by adding 1 N HCl into MH and veriﬁed
using a pH meter (SB20; VWR), with and without supplementation with 100 M iron(III) citrate. For these
growth experiments, cells were incubated shaking microaerobically at 38°C, and cell viability was
measured by dilution plating at the indicated times. For antibiotic testing, cells were inoculated into
96-well plates at a ﬁnal OD600 of 0.02 in 0.2 ml of MH or MH plus 100 M iron(III) citrate containing
doubling dilutions of streptomycin from 0.03 to 16 M. The plates were incubated at 38°C for 48 h. The
wells were mixed by pipetting and measured using the Varioscan Flash spectrophotometer at OD600. All
experiments were performed in triplicate, with each experiment including three technical replicates.
Measuring growth in iron-depleted medium supplemented with extracts. Log-phase C. jejuni
cells of the 81-176, 1651–1656, 1651–1656C, p19, and p19C strains were inoculated at a ﬁnal OD600 of
0.005 into 200 l of MH, MH plus 15 M DFO, MH plus 15 MDFO plus 10% CP/HP1/HP2/HP3, or MH plus
15 M DFO plus 10 M iron(III) citrate in 96-well plates. Plates were incubated at 38°C microaerobically.
At each time point, the wells were mixed, cell density was measured at OD600, and CFU measured by
dilution plating 10 l of each culture. Experiments were performed in triplicate.
Statistics. The P values for gene expression fold change derived from RNA sequencing data were
calculated by the DESeq2 package. Brieﬂy, DESeq2 uses the Benjamini-Hochberg (BH) adjustment to
calculate the padj value, which represents the false-discovery rate of genes should the null hypothesis (i.e.,
no genes are affected) be true (84). Genes with padj values (shown as P values in Tables 1 to 3; see
Table S2) lower than 0.05 were selected for this study. C. jejuni growth and bioﬁlm data were analyzed
and graphed using Graphpad Prism 7, and statistical differences were calculated using the Student’s
t test. Statistical analysis of the ICP-MS data was calculated using analysis of variance (ANOVA).
Availability of data. The transcriptome (RNA-seq) sequence data for this study have been submitted
to the European Nucleotide Archive (ENA). The accession numbers can be found in Table S1.
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